0001474064-11-000017.txt : 20110523 0001474064-11-000017.hdr.sgml : 20110523 20110523160413 ACCESSION NUMBER: 0001474064-11-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110519 FILED AS OF DATE: 20110523 DATE AS OF CHANGE: 20110523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANADILLO PEDRO P CENTRAL INDEX KEY: 0001217544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 11865086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2011-05-19 0000890465 NPS PHARMACEUTICALS INC NPSP 0001217544 GRANADILLO PEDRO P 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Deferred Stock Units 2011-05-19 4 A 0 756 0 A Common Stock 756 4346 D Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock. Deferred Stock Units awarded under the NPS Pharmaceuticals, Inc. 2007 Nonemployee Directors' Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company. /s/ Edward Stratemeier as Attorney-in-fact 2011-05-23